IQVIA Holdings Inc.
https://www.iqvia.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From IQVIA Holdings Inc.
COVID-19 Vaccine Trial Efficiencies, Leadership Alignment: What Can Be Carried Forward
Operational actions, organizational responses and clinical development model improvements led to a 26-month acceleration, on average, in a set of COVID-19 vaccine pivotal trials versus similarly sized pre-pandemic studies, with the database lock and analysis stage delivering dramatic gains, a study by IQVIA Institute indicates. Can these benefits be recapitulated across the portfolio in the post-pandemic era?
Back To Normal-ish: What To Expect As Pharma Resumes In-Person Gatherings
With the mask mandate now lifted for air travel and the grimmer milestone of one million Americans dead from COVID approaching, the Pink Sheet looks back at the generic trade association’s annual meeting to see what business gatherings may look like going forward.
Foreign Firms Not Fatigued In India, Game For 'New Things'
Senior management executives of Roche, Bayer, AstraZeneca, Pfizer and Novo Nordisk in India signal momentum in product launch and clinical trial activity, belying apprehension of wider cutbacks by foreign firms in the country, though one executive stressed that “tried and tested models” may not work in the largely self-pay market.
Generics Firms Resign Themselves To A Merger Drought As Regulators Tighten Up
Unable to predict which divestures will be required by the EU or the US FTC, firms will instead look to private equity, their organic pipeline, or partnerships for growth, CEOs forecast on the last day of the generic trade association’s annual meeting.
Company Information
- Industry
- Contract Research Organization-CRO
- Services
- Other Names / Subsidiaries
-
- Quintiles
- IMS Health, IQVIA Biotech LLC, Novasyte, LLC
- Myriad RBM Inc.